Literature DB >> 308101

Distribution of T-lymphocytes and B-lymphocytes in peripheral blood and effusions of patients with cancer.

W Domagala, E E Emeson, L G Koss.   

Abstract

The relative distribution of T- and B-lymphocytes in the blood and in pleural or abdominal effusions was compared among 24 patients with fluid accumulation due to metastatic cancer and 8 patients without evidence of cancer. The data obtained indicated that the mean percentage of T-lymphocytes in malignant effusions was significantly greater than that in the peripheral blood of the same patients. At the same time, the mean eprcentage of B-lymphocytes was decreased in malignant effusions when compared with peripheral blood. Neither of these differences was observed when effusions and blood of patients with nonmalignant effusions were compared. In addition, patients with both types of effusions had fewer total lymphocytes in their blood than did normal control patients, whereas those with cancer-associated effusions had an increased proportion of active T-lymphocytes in their blood.

Entities:  

Mesh:

Year:  1978        PMID: 308101

Source DB:  PubMed          Journal:  J Natl Cancer Inst        ISSN: 0027-8874            Impact factor:   13.506


  4 in total

Review 1.  Pathogenesis of pleurisy, pleural fibrosis, and mesothelial proliferation.

Authors:  A Herbert
Journal:  Thorax       Date:  1986-03       Impact factor: 9.139

2.  A comparative study of lymphocytes in effusions of patients with tuberculosis or malignant disease.

Authors:  R P Falcão; C Bottura
Journal:  Clin Exp Immunol       Date:  1981-07       Impact factor: 4.330

3.  Modulation of tumour colony growth by irradiated accessory cells.

Authors:  A W Hamburger; C P White; F E Dunn
Journal:  Br J Cancer       Date:  1983-11       Impact factor: 7.640

4.  Canine transmissible venereal sarcoma: distribution of T and B lymphocytes in blood, draining lymph nodes and tumours at different stages of growth.

Authors:  J P Chandler; T J Yang
Journal:  Br J Cancer       Date:  1981-10       Impact factor: 7.640

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.